The	O	0,3
median	O	4,10
interval	O	11,19
between	O	20,27
the	O	28,31
onset	O	32,37
of	O	38,40
FP	B-KP	41,43
and	O	44,47
the	O	48,51
assessment	O	52,62
of	O	63,65
antibodies	B-KP	66,76
to	O	77,79
B	B-KP	80,81
.	I-KP	81,82
burgdorferi	I-KP	83,94
was	O	95,98
4	O	99,100
days	O	101,105
(	O	106,107
range	O	107,112
,	O	112,113
0-20	O	114,118
days	O	119,123
)	O	123,124
.	O	124,125

In	O	126,128
the	O	129,132
LB	B-KP	133,135
group	O	136,141
the	O	142,145
geometric	O	146,155
mean	O	156,160
levels	O	161,167
of	O	168,170
the	O	171,174
serum	O	175,180
IgM	O	181,184
and	O	185,188
IgG	O	189,192
antibodies	O	193,203
to	O	204,206
B	O	207,208
.	O	208,209
burgdorferi	O	210,221
were	O	222,226
2.3-fold	O	227,235
and	O	236,239
3.2-fold	O	240,248
higher	O	249,255
than	O	256,260
the	O	261,264
cutoff	O	265,271
limits	O	272,278
,	O	278,279
respectively	O	280,292
.	O	292,293

Three	O	294,299
patients	O	300,308
had	O	309,312
IgG	B-KP	313,316
antibodies	B-KP	317,327
only	O	328,332
,	O	332,333
and	O	334,337
7	O	338,339
patients	O	340,348
had	O	349,352
both	O	353,357
IgG	B-KP	358,361
and	O	362,365
IgM	B-KP	366,369
antibodies	B-KP	370,380
.	O	380,381

None	O	382,386
of	O	387,389
the	O	390,393
patients	O	394,402
had	O	403,406
IgM	B-KP	407,410
antibodies	B-KP	411,421
only	O	422,426
.	O	426,427

The	O	428,431
T	B-KP	432,433
.	I-KP	433,434
pallidum	I-KP	435,443
hemagglutination	I-KP	444,460
assay	I-KP	461,466
was	O	467,470
done	O	471,475
for	O	476,479
8	O	480,481
of	O	482,484
the	O	485,488
11	O	489,491
cases	O	492,497
,	O	497,498
and	O	499,502
it	O	503,505
was	O	506,509
negative	O	510,518
in	O	519,521
all	O	522,525
of	O	526,528
them	O	529,533
.	O	533,534

CSF	B-KP	535,538
specimens	O	539,548
from	O	549,553
the	O	554,557
11	O	558,560
patients	O	561,569
with	O	570,574
LB	B-KP	575,577
were	O	578,582
analyzed	O	583,591
on	O	592,594
admission	O	595,604
,	O	604,605
and	O	606,609
9	O	610,611
of	O	612,614
them	O	615,619
showed	O	620,626
abnormalities	O	627,640
.	O	640,641

Eight	O	642,647
(	O	648,649
73	O	649,651
%	O	651,652
)	O	652,653
were	O	654,658
positive	O	659,667
for	O	668,671
antibodies	B-KP	672,682
to	O	683,685
B	B-KP	686,687
.	I-KP	687,688
burgdorferi	I-KP	689,700
.	O	700,701

Five	O	702,706
patients	O	707,715
had	O	716,719
both	O	720,724
IgM	B-KP	725,728
and	O	729,732
IgG	B-KP	733,736
antibodies	B-KP	737,747
,	O	747,748
1	O	749,750
had	O	751,754
IgM	B-KP	755,758
antibodies	B-KP	759,769
only	O	770,774
(	O	775,776
IgG	B-KP	776,779
antibodies	B-KP	780,790
not	O	791,794
done	O	795,799
)	O	799,800
,	O	800,801
and	O	802,805
2	O	806,807
had	O	808,811
IgG	B-KP	812,815
antibodies	B-KP	816,826
only	O	827,831
.	O	831,832

The	O	833,836
geometric	O	837,846
mean	O	847,851
levels	O	852,858
of	O	859,861
the	O	862,865
IgM	B-KP	866,869
and	O	870,873
IgG	B-KP	874,877
antibodies	B-KP	878,888
were	O	889,893
46-fold	O	894,901
(	O	902,903
range	O	903,908
,	O	908,909
3.3-530)	O	910,918
and	O	919,922
24-fold	O	923,930
(	O	931,932
range	O	932,937
,	O	937,938
2.3-330)	O	939,947
higher	O	948,954
than	O	955,959
the	O	960,963
cutoff	O	964,970
limits	O	971,977
,	O	977,978
respectively	O	979,991
.	O	991,992

The	O	993,996
Borrelia	B-KP	997,1005
PCR	B-KP	1006,1009
test	I-KP	1010,1014
was	O	1015,1018
carried	O	1019,1026
out	O	1027,1030
on	O	1031,1033
CSF	B-KP	1034,1037
samples	O	1038,1045
of	O	1046,1048
10	O	1049,1051
of	O	1052,1054
the	O	1055,1058
11	O	1059,1061
patients	O	1062,1070
and	O	1071,1074
the	O	1075,1078
sera	O	1079,1083
of	O	1084,1086
9	O	1087,1088
of	O	1089,1091
the	O	1092,1095
11	O	1096,1098
patients	O	1099,1107
;	O	1107,1108
the	O	1109,1112
test	O	1113,1117
was	O	1118,1121
positive	O	1122,1130
for	O	1131,1134
one	O	1135,1138
CSF	B-KP	1139,1142
sample	O	1143,1149
only	O	1150,1154
.	O	1154,1155

Five	O	1156,1160
(	O	1161,1162
45	O	1162,1164
%	O	1164,1165
)	O	1165,1166
of	O	1167,1169
the	O	1170,1173
patients	O	1174,1182
had	O	1183,1186
pleocytosis	B-KP	1187,1198
in	O	1199,1201
the	O	1202,1205
CSF	B-KP	1206,1209
(	O	1210,1211
geometric	O	1211,1220
mean	O	1221,1225
of	O	1226,1228
the	O	1229,1232
leukocyte	O	1233,1242
count	O	1243,1248
,	O	1248,1249
148	O	1250,1253
106	O	1254,1257
/	O	1257,1258
L;	O	1258,1260
range	O	1261,1266
,	O	1266,1267
26-560	O	1268,1274
106	O	1275,1278
/	O	1278,1279
L).	O	1279,1282

An	O	1283,1285
elevated	O	1286,1294
protein	O	1295,1302
concentration	O	1303,1316
(	O	1317,1318
mean	O	1318,1322
,	O	1322,1323
2,780	O	1324,1329
mg	O	1330,1332
/	O	1332,1333
L;	O	1333,1335
range	O	1336,1341
,	O	1341,1342
1,420-4,370	O	1343,1354
mg	O	1355,1357
/	O	1357,1358
L)	O	1358,1360
was	O	1361,1364
found	O	1365,1370
in	O	1371,1373
three	O	1374,1379
patients	O	1380,1388
.	O	1388,1389

